doi: 10.3389/fphar.2025.1526270 Received 11 November 2024 Accepted 28 January 2025 Published 17 February 2025 Volume 16 - 2025 Edited by Alessandra Linardi, Santa Casa de So Paulo School of Medical Sciences, Brazil Reviewed by David Pubill, University of Barcelona, Spain Ariadiny Lima Caetano, Santa Casa de So Paulo School of Medical, Brazil Updates Copyright 2025 Wang, Hao, Ma, Feng, Yang, An, Su and Feng
Clean Ingredients: Ensure there are no synthetic fillers, artificial flavors, or unnecessary binders
Oral tirzepatide versus injection comparisons are becoming more relevant as oral tirzepatide formulations enter development
The Company partners with medical providers to take a complete approach to healthier aging through patient-specific bioidentical hormone replacement therapy and superior nutraceuticals
This is why ex vivo findings need to be confirmed in human trials which subsequent studies like the 2016 GHK peptide clinical trial and the 2021 copper tripeptide serum trial have done